IBDEI20H ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32103,0)
;;=Z30.46^^126^1646^19
;;^UTILITY(U,$J,358.3,32103,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32103,1,3,0)
;;=3^Surveillance Implantable Subdermal (Nexplanon),F/U
;;^UTILITY(U,$J,358.3,32103,1,4,0)
;;=4^Z30.46
;;^UTILITY(U,$J,358.3,32103,2)
;;=^5140424
;;^UTILITY(U,$J,358.3,32104,0)
;;=Z30.45^^126^1646^20
;;^UTILITY(U,$J,358.3,32104,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32104,1,3,0)
;;=3^Surveillance Transdermal Patch Hormonal (Ortho Evra),F/U
;;^UTILITY(U,$J,358.3,32104,1,4,0)
;;=4^Z30.45
;;^UTILITY(U,$J,358.3,32104,2)
;;=^5140423
;;^UTILITY(U,$J,358.3,32105,0)
;;=Z30.44^^126^1646^21
;;^UTILITY(U,$J,358.3,32105,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32105,1,3,0)
;;=3^Surveillance Vaginal Ring Hormonal (NuvaRing),F/U
;;^UTILITY(U,$J,358.3,32105,1,4,0)
;;=4^Z30.44
;;^UTILITY(U,$J,358.3,32105,2)
;;=^5140422
;;^UTILITY(U,$J,358.3,32106,0)
;;=Z30.016^^126^1646^22
;;^UTILITY(U,$J,358.3,32106,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32106,1,3,0)
;;=3^Transdermal Patch Hormonal Device (Ortho Evra),Initial
;;^UTILITY(U,$J,358.3,32106,1,4,0)
;;=4^Z30.016
;;^UTILITY(U,$J,358.3,32106,2)
;;=^5140420
;;^UTILITY(U,$J,358.3,32107,0)
;;=Z30.015^^126^1646^24
;;^UTILITY(U,$J,358.3,32107,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32107,1,3,0)
;;=3^Vaginal Ring Hormonal (NuvaRing),Initial
;;^UTILITY(U,$J,358.3,32107,1,4,0)
;;=4^Z30.015
;;^UTILITY(U,$J,358.3,32107,2)
;;=^5140419
;;^UTILITY(U,$J,358.3,32108,0)
;;=Z90.710^^126^1647^1
;;^UTILITY(U,$J,358.3,32108,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32108,1,3,0)
;;=3^Acquired Absence of Cervix & Uterus
;;^UTILITY(U,$J,358.3,32108,1,4,0)
;;=4^Z90.710
;;^UTILITY(U,$J,358.3,32108,2)
;;=^5063591
;;^UTILITY(U,$J,358.3,32109,0)
;;=Z90.712^^126^1647^2
;;^UTILITY(U,$J,358.3,32109,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32109,1,3,0)
;;=3^Acquired Absence of Cervix w/ Remaining Uterus
;;^UTILITY(U,$J,358.3,32109,1,4,0)
;;=4^Z90.712
;;^UTILITY(U,$J,358.3,32109,2)
;;=^5063593
;;^UTILITY(U,$J,358.3,32110,0)
;;=R87.619^^126^1647^3
;;^UTILITY(U,$J,358.3,32110,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32110,1,3,0)
;;=3^Atypical Gland Cells,Undet Signif (AGCUS) Pap
;;^UTILITY(U,$J,358.3,32110,1,4,0)
;;=4^R87.619
;;^UTILITY(U,$J,358.3,32110,2)
;;=^5019676
;;^UTILITY(U,$J,358.3,32111,0)
;;=R87.611^^126^1647^4
;;^UTILITY(U,$J,358.3,32111,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32111,1,3,0)
;;=3^Atypical Squam Cell,Not Excl Hi Grd Intrepith Lesn Cyto Smr Crvx
;;^UTILITY(U,$J,358.3,32111,1,4,0)
;;=4^R87.611
;;^UTILITY(U,$J,358.3,32111,2)
;;=^5019669
;;^UTILITY(U,$J,358.3,32112,0)
;;=D06.9^^126^1647^5
;;^UTILITY(U,$J,358.3,32112,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32112,1,3,0)
;;=3^CA in Situ,Cervix
;;^UTILITY(U,$J,358.3,32112,1,4,0)
;;=4^D06.9
;;^UTILITY(U,$J,358.3,32112,2)
;;=^5001941
;;^UTILITY(U,$J,358.3,32113,0)
;;=D06.1^^126^1647^7
;;^UTILITY(U,$J,358.3,32113,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32113,1,3,0)
;;=3^CA in Situ,Exocervix
;;^UTILITY(U,$J,358.3,32113,1,4,0)
;;=4^D06.1
;;^UTILITY(U,$J,358.3,32113,2)
;;=^5001939
;;^UTILITY(U,$J,358.3,32114,0)
;;=D06.0^^126^1647^6
;;^UTILITY(U,$J,358.3,32114,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32114,1,3,0)
;;=3^CA in Situ,Endocervix
;;^UTILITY(U,$J,358.3,32114,1,4,0)
;;=4^D06.0
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI20H 3765 printed Sep 23, 2025@19:55:23 Page 2
IBDEI20H ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32103,0)
+2 ;;=Z30.46^^126^1646^19
+3 ;;^UTILITY(U,$J,358.3,32103,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,32103,1,3,0)
+6 ;;=3^Surveillance Implantable Subdermal (Nexplanon),F/U
+7 ;;^UTILITY(U,$J,358.3,32103,1,4,0)
+8 ;;=4^Z30.46
+9 ;;^UTILITY(U,$J,358.3,32103,2)
+10 ;;=^5140424
+11 ;;^UTILITY(U,$J,358.3,32104,0)
+12 ;;=Z30.45^^126^1646^20
+13 ;;^UTILITY(U,$J,358.3,32104,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,32104,1,3,0)
+16 ;;=3^Surveillance Transdermal Patch Hormonal (Ortho Evra),F/U
+17 ;;^UTILITY(U,$J,358.3,32104,1,4,0)
+18 ;;=4^Z30.45
+19 ;;^UTILITY(U,$J,358.3,32104,2)
+20 ;;=^5140423
+21 ;;^UTILITY(U,$J,358.3,32105,0)
+22 ;;=Z30.44^^126^1646^21
+23 ;;^UTILITY(U,$J,358.3,32105,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,32105,1,3,0)
+26 ;;=3^Surveillance Vaginal Ring Hormonal (NuvaRing),F/U
+27 ;;^UTILITY(U,$J,358.3,32105,1,4,0)
+28 ;;=4^Z30.44
+29 ;;^UTILITY(U,$J,358.3,32105,2)
+30 ;;=^5140422
+31 ;;^UTILITY(U,$J,358.3,32106,0)
+32 ;;=Z30.016^^126^1646^22
+33 ;;^UTILITY(U,$J,358.3,32106,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,32106,1,3,0)
+36 ;;=3^Transdermal Patch Hormonal Device (Ortho Evra),Initial
+37 ;;^UTILITY(U,$J,358.3,32106,1,4,0)
+38 ;;=4^Z30.016
+39 ;;^UTILITY(U,$J,358.3,32106,2)
+40 ;;=^5140420
+41 ;;^UTILITY(U,$J,358.3,32107,0)
+42 ;;=Z30.015^^126^1646^24
+43 ;;^UTILITY(U,$J,358.3,32107,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,32107,1,3,0)
+46 ;;=3^Vaginal Ring Hormonal (NuvaRing),Initial
+47 ;;^UTILITY(U,$J,358.3,32107,1,4,0)
+48 ;;=4^Z30.015
+49 ;;^UTILITY(U,$J,358.3,32107,2)
+50 ;;=^5140419
+51 ;;^UTILITY(U,$J,358.3,32108,0)
+52 ;;=Z90.710^^126^1647^1
+53 ;;^UTILITY(U,$J,358.3,32108,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,32108,1,3,0)
+56 ;;=3^Acquired Absence of Cervix & Uterus
+57 ;;^UTILITY(U,$J,358.3,32108,1,4,0)
+58 ;;=4^Z90.710
+59 ;;^UTILITY(U,$J,358.3,32108,2)
+60 ;;=^5063591
+61 ;;^UTILITY(U,$J,358.3,32109,0)
+62 ;;=Z90.712^^126^1647^2
+63 ;;^UTILITY(U,$J,358.3,32109,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,32109,1,3,0)
+66 ;;=3^Acquired Absence of Cervix w/ Remaining Uterus
+67 ;;^UTILITY(U,$J,358.3,32109,1,4,0)
+68 ;;=4^Z90.712
+69 ;;^UTILITY(U,$J,358.3,32109,2)
+70 ;;=^5063593
+71 ;;^UTILITY(U,$J,358.3,32110,0)
+72 ;;=R87.619^^126^1647^3
+73 ;;^UTILITY(U,$J,358.3,32110,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,32110,1,3,0)
+76 ;;=3^Atypical Gland Cells,Undet Signif (AGCUS) Pap
+77 ;;^UTILITY(U,$J,358.3,32110,1,4,0)
+78 ;;=4^R87.619
+79 ;;^UTILITY(U,$J,358.3,32110,2)
+80 ;;=^5019676
+81 ;;^UTILITY(U,$J,358.3,32111,0)
+82 ;;=R87.611^^126^1647^4
+83 ;;^UTILITY(U,$J,358.3,32111,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,32111,1,3,0)
+86 ;;=3^Atypical Squam Cell,Not Excl Hi Grd Intrepith Lesn Cyto Smr Crvx
+87 ;;^UTILITY(U,$J,358.3,32111,1,4,0)
+88 ;;=4^R87.611
+89 ;;^UTILITY(U,$J,358.3,32111,2)
+90 ;;=^5019669
+91 ;;^UTILITY(U,$J,358.3,32112,0)
+92 ;;=D06.9^^126^1647^5
+93 ;;^UTILITY(U,$J,358.3,32112,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,32112,1,3,0)
+96 ;;=3^CA in Situ,Cervix
+97 ;;^UTILITY(U,$J,358.3,32112,1,4,0)
+98 ;;=4^D06.9
+99 ;;^UTILITY(U,$J,358.3,32112,2)
+100 ;;=^5001941
+101 ;;^UTILITY(U,$J,358.3,32113,0)
+102 ;;=D06.1^^126^1647^7
+103 ;;^UTILITY(U,$J,358.3,32113,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,32113,1,3,0)
+106 ;;=3^CA in Situ,Exocervix
+107 ;;^UTILITY(U,$J,358.3,32113,1,4,0)
+108 ;;=4^D06.1
+109 ;;^UTILITY(U,$J,358.3,32113,2)
+110 ;;=^5001939
+111 ;;^UTILITY(U,$J,358.3,32114,0)
+112 ;;=D06.0^^126^1647^6
+113 ;;^UTILITY(U,$J,358.3,32114,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,32114,1,3,0)
+116 ;;=3^CA in Situ,Endocervix
+117 ;;^UTILITY(U,$J,358.3,32114,1,4,0)
+118 ;;=4^D06.0
